Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 26.75 is 223% above its 3-year average of 8.27, near the high end of its 3-year range (0.00–26.75).
As of the fiscal period ended Tuesday, June 30, 2026. 82.24% above its 12-month average of 14.68.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 26.75.
CURRENT RATIO
26.75
CURRENT RATIO AVG TTM
14.68
CURRENT RATIO AVG 3Y
11.09
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+82.24%
CURRENT VS 3Y AVG
+141.26%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
+647.11%
vs the sector median at left
OnKure Therapeutics, Inc.
Market Cap
$102.86M
Current Ratio
26.75
TTM Avg
14.68
3Y Avg
11.09
5Y Avg
N/A
Market Cap
$102.84M
Current Ratio
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.36
Market Cap
$104.68M
Current Ratio
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$105.13M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
Market Cap
$107.65M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $102.86M | 26.75 | 14.68 | 11.09 | N/A |
| The Joint Corp. (JYNT)vs › | $102.85M | 1.83 | 1.56 | 1.30 | 1.30 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.84M | 8.54 | 8.31 | 10.99 | 13.36 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| Definitive Healthcare Corp. (DH)vs › | $105.13M | 1.86 | 1.97 | 2.28 | 2.24 |
| PolyPid Ltd. (PYPD)vs › | $98.56M | 1.35 | 1.64 | 1.44 | 4.41 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.65M | 5.71 | 10.50 | 6.63 | 5.88 |
| Korro Bio, Inc. (KRRO)vs › | $97.84M | 9.55 | 7.84 | 7.78 | 8.56 |
| Conexeu Sciences Inc. (CNXU)vs › | $98.07M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.13M | 8.13 | 8.55 | 9.73 | 13.44 |
Current Ratio
26.75
Quick Ratio
26.75
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 26.75 |
| 2026-03-31 | 13.78 |
| 2025-12-31 | 10.28 |
| 2025-09-30 | 11.45 |
| 2025-06-30 | 11.13 |
| 2025-03-31 | 11.17 |
| 2024-12-31 | 10.73 |
| 2024-09-30 | 23.71 |
| 2024-06-30 | 1.83 |
| 2024-03-31 | 4.09 |
| 2023-12-31 | 4.64 |
| 2023-09-30 | 9.49 |
| 2023-06-30 | 10.65 |
| 2023-03-31 | 0.00 |
